×
About 230,774 results

ALLMedicine™ Type 2 Diabetes Center

Research & Reviews  110,097 results

Metabolic profiling of pre-gestational and gestational diabetes mellitus identifies nov...
https://doi.org/10.1186/s12967-020-02531-5
Journal of Translational Medicine; Diboun I, Ramanjaneya M et. al.

Sep 25th, 2020 - Pregnant women with gestational diabetes mellitus (GDM) or type 2 diabetes mellitus (T2DM) are at increased risks of pre-term labor, hypertension and preeclampsia. In this study, metabolic profiling of blood samples collected from GDM, T2DM and co...

Pharmacologic Glycemic Management of Type 2 Diabetes in Adults: 2020 Update.
https://doi.org/10.1016/j.jcjd.2020.08.001
Canadian Journal of Diabetes; , Lipscombe L et. al.

Sep 25th, 2020 - Pharmacologic Glycemic Management of Type 2 Diabetes in Adults: 2020 Update.|2020| ,Lipscombe L,Butalia S,Dasgupta K,Eurich DT,|

Pharmacologic Glycemic Management of Type 2 Diabetes in Adults: 2020 Update - The User'...
https://doi.org/10.1016/j.jcjd.2020.08.002
Canadian Journal of Diabetes; , Senior PA et. al.

Sep 25th, 2020 - Pharmacologic Glycemic Management of Type 2 Diabetes in Adults: 2020 Update - The User's Guide.|2020| ,Senior PA,Houlden RL,Kim J,Mackay D,|

Switching between GLP-1 receptor agonists in clinical practice: expert consensus and pr...
https://doi.org/10.1111/ijcp.13731
International Journal of Clinical Practice; Jain AB, Ali A et. al.

Sep 25th, 2020 - Glucagon-like peptide-1 receptor agonists (GLP-1RAs) are an established treatment for patients with type 2 diabetes (T2D). Differences between GLP-1RAs in pharmacokinetics, dosing regimens and clinical effects, including cardiovascular (CV) outcom...

Role of Gut Microbiome and Microbial Metabolites in Alleviating Insulin Resistance Afte...
https://doi.org/10.1007/s11695-020-04974-7
Obesity Surgery; Wang M, Li L et. al.

Sep 25th, 2020 - Insulin resistance (IR) is the most common pathophysiological change in patients with type 2 diabetes mellitus (T2DM). Several recent studies have suggested that the gut microbiome and microbial metabolites are involved in the pathogenesis of IR. ...

see more →

Guidelines  367 results

2020 Expert Consensus Decision Pathway on Novel Therapies for Cardiovascular Risk Reduc...
https://doi.org/10.1016/j.jacc.2020.05.037
Journal of the American College of Cardiology; Das SR, Everett BM et. al.

Aug 10th, 2020 - 2020 Expert Consensus Decision Pathway on Novel Therapies for Cardiovascular Risk Reduction in Patients With Type 2 Diabetes: A Report of the American College of Cardiology Solution Set Oversight Committee.|2020|Das SR,Everett BM,Birtcher KK,Brown...

Risk of incident type 2 diabetes among patients with rheumatoid arthritis: a population‐based cohort study
https://onlinelibrary.wiley.com/doi/abs/10.1002/acr.24343
Arthritis Care & Research; Jin Y

Aug 2nd, 2020 - We examined risk of incident type 2 diabetes mellitus (T2DM) among RA patients versus four different comparison cohorts.

New American Diabetes Association (ADA)/European Association for the Study of Diabetes ...
https://doi.org/10.1016/j.metabol.2020.154218
Metabolism: Clinical and Experimental; Katsiki N, Ferrannini E et. al.

Mar 30th, 2020 - New American Diabetes Association (ADA)/European Association for the Study of Diabetes (EASD) guidelines for the pharmacotherapy of type 2 diabetes: Placing them into a practicing physician's perspective.|2020|Katsiki N,Ferrannini E,Mantzoros C,|d...

Short-Term Consumption of Sucralose with, but Not without, Carbohydrate Impairs Neural and Metabolic Sensitivity to Sugar in Humans
https://www.cell.com/cell-metabolism/fulltext/S1550-4131(20)30057-7
Cell Metabolism; Dalenberg JR,et al

Mar 2nd, 2020 - There is a general consensus that overconsumption of sugar-sweetened beverages contributes to the prevalence of obesity and related comorbidities such as type 2 diabetes (T2D). Whether a similar relationship exists for no- or low-calorie “diet” dr...

2019 Update to: Management of Hyperglycemia in Type 2 Diabetes, 2018. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
https://care.diabetesjournals.org/content/43/2/487
Diabetes Care; Buse JB,et al

Dec 18th, 2019 - The American Diabetes Association and the European Association for the Study of Diabetes have briefly updated their 2018 recommendations on management of hyperglycemia, based on important research findings from large cardiovascular outcomes trials...

see more →

Drugs  2,369 results see all →

Clinicaltrials.gov  113,837 results

Metabolic profiling of pre-gestational and gestational diabetes mellitus identifies nov...
https://doi.org/10.1186/s12967-020-02531-5
Journal of Translational Medicine; Diboun I, Ramanjaneya M et. al.

Sep 25th, 2020 - Pregnant women with gestational diabetes mellitus (GDM) or type 2 diabetes mellitus (T2DM) are at increased risks of pre-term labor, hypertension and preeclampsia. In this study, metabolic profiling of blood samples collected from GDM, T2DM and co...

Pharmacologic Glycemic Management of Type 2 Diabetes in Adults: 2020 Update.
https://doi.org/10.1016/j.jcjd.2020.08.001
Canadian Journal of Diabetes; , Lipscombe L et. al.

Sep 25th, 2020 - Pharmacologic Glycemic Management of Type 2 Diabetes in Adults: 2020 Update.|2020| ,Lipscombe L,Butalia S,Dasgupta K,Eurich DT,|

Pharmacologic Glycemic Management of Type 2 Diabetes in Adults: 2020 Update - The User'...
https://doi.org/10.1016/j.jcjd.2020.08.002
Canadian Journal of Diabetes; , Senior PA et. al.

Sep 25th, 2020 - Pharmacologic Glycemic Management of Type 2 Diabetes in Adults: 2020 Update - The User's Guide.|2020| ,Senior PA,Houlden RL,Kim J,Mackay D,|

Switching between GLP-1 receptor agonists in clinical practice: expert consensus and pr...
https://doi.org/10.1111/ijcp.13731
International Journal of Clinical Practice; Jain AB, Ali A et. al.

Sep 25th, 2020 - Glucagon-like peptide-1 receptor agonists (GLP-1RAs) are an established treatment for patients with type 2 diabetes (T2D). Differences between GLP-1RAs in pharmacokinetics, dosing regimens and clinical effects, including cardiovascular (CV) outcom...

Role of Gut Microbiome and Microbial Metabolites in Alleviating Insulin Resistance Afte...
https://doi.org/10.1007/s11695-020-04974-7
Obesity Surgery; Wang M, Li L et. al.

Sep 25th, 2020 - Insulin resistance (IR) is the most common pathophysiological change in patients with type 2 diabetes mellitus (T2DM). Several recent studies have suggested that the gut microbiome and microbial metabolites are involved in the pathogenesis of IR. ...

see more →

News  4,021 results

Risk of incident type 2 diabetes among patients with rheumatoid arthritis: a population‐based cohort study
https://onlinelibrary.wiley.com/doi/abs/10.1002/acr.24343
Arthritis Care & Research; Jin Y

Aug 2nd, 2020 - We examined risk of incident type 2 diabetes mellitus (T2DM) among RA patients versus four different comparison cohorts.

Low fitness level linked to higher risk of heart failure in diabetes
https://www.mdedge.com/endocrinology/article/219455/heart-failure/low-fitness-level-linked-higher-risk-heart-failure?channel=39313
Doug Brunk

Mar 23rd, 2020 - PHOENIX – Lower baseline fitness and greater decline in fitness over time are independently associated with a higher risk of heart failure in patients with diabetes, results from a large analysis showed. Doug Brunk/MDedge News Dr.

FDA advises stopping SGLT2 inhibitor treatment prior to surgery
https://www.mdedge.com/jcomjournal/article/219251/diabetes/fda-advises-stopping-sglt2-inhibitor-treatment-prior-surgery?channel=302
Lucas Franki

Mar 18th, 2020 - The Food and Drug Administration has approved safety labeling changes to all sodium-glucose transporter 2 (SGLT2) inhibitors used to treat high blood sugar in patients with type 2 diabetes. The new changes affect canagliflozin, dapagliflozin, empa.

Study links GLP-1R agonists, lower inflammatory biomarker levels
https://www.mdedge.com/pulmonary-health-hub/article/219245/asthma/study-links-glp-1r-agonists-lower-inflammatory-biomarker?channel=94
Richard Mark Kirkner

Mar 18th, 2020 - Patients with both type 2 diabetes and asthma who were on glucagonlike peptide receptor–1 (GLP-1R) agonists for glucose control had lower levels of a key biomarker of airway inflammation than similar patients on other types of glucose-control medi.

Smoking, hypoglycemia, kidney function tied to vision loss in type 2 diabetes
https://www.mdedge.com/familymedicine/article/219004/diabetes/smoking-hypoglycemia-kidney-function-tied-vision-loss-type-2?channel=255
MDedge Endocrinology; Steve Cimino

Mar 13th, 2020 - Several risk factors, including smoking, a previous severe hypoglycemic event, and poorly functioning kidneys, can lead to vision loss in patients with type 2 diabetes, according to new findings published in the Journal of Diabetes and its Complic.

see more →

Patient Education  83 results see all →